Mitesco, Inc.
Mitesco, Inc. (MITI) Stock Competitors & Peer Comparison
See (MITI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MITI | $0.12 | +0.00% | 1.2M | -0.16 | -$0.73 | N/A |
| PMCUF | $94.03 | -2.15% | 9.8B | 60.28 | $1.56 | +0.45% |
| MTHRY | $5.09 | +2.00% | 6.9B | 24.29 | $0.21 | +0.97% |
| MTHRF | $9.90 | -13.31% | 6.7B | 23.02 | $0.43 | +1.40% |
| PANHF | $1.55 | -12.22% | 3.3B | 154.50 | $0.01 | N/A |
| PIAHY | $4.40 | +0.00% | 2.4B | 146.67 | $0.03 | N/A |
| CMPVF | $33.66 | +11.64% | 1.7B | 58.03 | $0.58 | +0.17% |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| CRWRF | $24.20 | +0.00% | 850.6M | 44.00 | $0.55 | +1.73% |
| RSLBF | $23.00 | +0.00% | 822.2M | 32.39 | $0.71 | +1.37% |
Stock Comparison
MITI vs PMCUF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, PMCUF has a market cap of 9.8B. Regarding current trading prices, MITI is priced at $0.12, while PMCUF trades at $94.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas PMCUF's P/E ratio is 60.28. In terms of profitability, MITI's ROE is +0.17%, compared to PMCUF's ROE of +0.73%. Regarding short-term risk, MITI is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check PMCUF's competition here
MITI vs MTHRY Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MTHRY has a market cap of 6.9B. Regarding current trading prices, MITI is priced at $0.12, while MTHRY trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MTHRY's P/E ratio is 24.29. In terms of profitability, MITI's ROE is +0.17%, compared to MTHRY's ROE of +0.13%. Regarding short-term risk, MITI is more volatile compared to MTHRY. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check MTHRY's competition here
MITI vs MTHRF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MTHRF has a market cap of 6.7B. Regarding current trading prices, MITI is priced at $0.12, while MTHRF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MTHRF's P/E ratio is 23.02. In terms of profitability, MITI's ROE is +0.17%, compared to MTHRF's ROE of +0.18%. Regarding short-term risk, MITI is more volatile compared to MTHRF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check MTHRF's competition here
MITI vs PANHF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, PANHF has a market cap of 3.3B. Regarding current trading prices, MITI is priced at $0.12, while PANHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas PANHF's P/E ratio is 154.50. In terms of profitability, MITI's ROE is +0.17%, compared to PANHF's ROE of +0.02%. Regarding short-term risk, MITI is more volatile compared to PANHF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check PANHF's competition here
MITI vs PIAHY Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, PIAHY has a market cap of 2.4B. Regarding current trading prices, MITI is priced at $0.12, while PIAHY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas PIAHY's P/E ratio is 146.67. In terms of profitability, MITI's ROE is +0.17%, compared to PIAHY's ROE of +0.02%. Regarding short-term risk, MITI is less volatile compared to PIAHY. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check PIAHY's competition here
MITI vs CMPVF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CMPVF has a market cap of 1.7B. Regarding current trading prices, MITI is priced at $0.12, while CMPVF trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CMPVF's P/E ratio is 58.03. In terms of profitability, MITI's ROE is +0.17%, compared to CMPVF's ROE of +0.03%. Regarding short-term risk, MITI is less volatile compared to CMPVF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check CMPVF's competition here
MITI vs CMPUY Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, MITI is priced at $0.12, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, MITI's ROE is +0.17%, compared to CMPUY's ROE of +0.02%. Regarding short-term risk, MITI is more volatile compared to CMPUY. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check CMPUY's competition here
MITI vs CRWRF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CRWRF has a market cap of 850.6M. Regarding current trading prices, MITI is priced at $0.12, while CRWRF trades at $24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CRWRF's P/E ratio is 44.00. In terms of profitability, MITI's ROE is +0.17%, compared to CRWRF's ROE of +0.07%. Regarding short-term risk, MITI is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check CRWRF's competition here
MITI vs RSLBF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, RSLBF has a market cap of 822.2M. Regarding current trading prices, MITI is priced at $0.12, while RSLBF trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas RSLBF's P/E ratio is 32.39. In terms of profitability, MITI's ROE is +0.17%, compared to RSLBF's ROE of +0.25%. Regarding short-term risk, MITI is more volatile compared to RSLBF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check RSLBF's competition here
MITI vs SMSZF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, SMSZF has a market cap of 702.6M. Regarding current trading prices, MITI is priced at $0.12, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas SMSZF's P/E ratio is 17.83. In terms of profitability, MITI's ROE is +0.17%, compared to SMSZF's ROE of +0.15%. Regarding short-term risk, MITI is less volatile compared to SMSZF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check SMSZF's competition here
MITI vs VHIBF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, VHIBF has a market cap of 357.3M. Regarding current trading prices, MITI is priced at $0.12, while VHIBF trades at $5.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas VHIBF's P/E ratio is 188.67. In terms of profitability, MITI's ROE is +0.17%, compared to VHIBF's ROE of +0.01%. Regarding short-term risk, MITI is more volatile compared to VHIBF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check VHIBF's competition here
MITI vs SMDCF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, MITI is priced at $0.12, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, MITI's ROE is +0.17%, compared to SMDCF's ROE of N/A. Regarding short-term risk, MITI is more volatile compared to SMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check SMDCF's competition here
MITI vs COGZF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, COGZF has a market cap of 265.9M. Regarding current trading prices, MITI is priced at $0.12, while COGZF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas COGZF's P/E ratio is 25.83. In terms of profitability, MITI's ROE is +0.17%, compared to COGZF's ROE of +0.27%. Regarding short-term risk, MITI is more volatile compared to COGZF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check COGZF's competition here
MITI vs DLHTF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, MITI is priced at $0.12, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, MITI's ROE is +0.17%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, MITI is more volatile compared to DLHTF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check DLHTF's competition here
MITI vs KSIOF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, KSIOF has a market cap of 249M. Regarding current trading prices, MITI is priced at $0.12, while KSIOF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas KSIOF's P/E ratio is -260.00. In terms of profitability, MITI's ROE is +0.17%, compared to KSIOF's ROE of -0.04%. Regarding short-term risk, MITI is more volatile compared to KSIOF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check KSIOF's competition here
MITI vs VPAHF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, MITI is priced at $0.12, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, MITI's ROE is +0.17%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, MITI is more volatile compared to VPAHF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check VPAHF's competition here
MITI vs ACMLF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, ACMLF has a market cap of 157M. Regarding current trading prices, MITI is priced at $0.12, while ACMLF trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas ACMLF's P/E ratio is 43.70. In terms of profitability, MITI's ROE is +0.17%, compared to ACMLF's ROE of +0.20%. Regarding short-term risk, MITI is more volatile compared to ACMLF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check ACMLF's competition here
MITI vs SUSRF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, SUSRF has a market cap of 144.9M. Regarding current trading prices, MITI is priced at $0.12, while SUSRF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas SUSRF's P/E ratio is 20.29. In terms of profitability, MITI's ROE is +0.17%, compared to SUSRF's ROE of +0.02%. Regarding short-term risk, MITI is more volatile compared to SUSRF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check SUSRF's competition here
MITI vs ONVVF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, ONVVF has a market cap of 122.8M. Regarding current trading prices, MITI is priced at $0.12, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, MITI's ROE is +0.17%, compared to ONVVF's ROE of -2.27%. Regarding short-term risk, MITI is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check ONVVF's competition here
MITI vs CSAMF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, MITI is priced at $0.12, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, MITI's ROE is +0.17%, compared to CSAMF's ROE of -1.12%. Regarding short-term risk, MITI is more volatile compared to CSAMF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check CSAMF's competition here
MITI vs HITC Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, MITI is priced at $0.12, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas HITC's P/E ratio is -14.75. In terms of profitability, MITI's ROE is +0.17%, compared to HITC's ROE of -0.78%. Regarding short-term risk, MITI is more volatile compared to HITC. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check HITC's competition here
MITI vs MDPEF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MDPEF has a market cap of 42.6M. Regarding current trading prices, MITI is priced at $0.12, while MDPEF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MDPEF's P/E ratio is 0.00. In terms of profitability, MITI's ROE is +0.17%, compared to MDPEF's ROE of N/A. Regarding short-term risk, MITI is more volatile compared to MDPEF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check MDPEF's competition here
MITI vs TREIF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, TREIF has a market cap of 36.6M. Regarding current trading prices, MITI is priced at $0.12, while TREIF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas TREIF's P/E ratio is -3.46. In terms of profitability, MITI's ROE is +0.17%, compared to TREIF's ROE of -3.04%. Regarding short-term risk, MITI is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check TREIF's competition here
MITI vs EMOR Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, EMOR has a market cap of 30.6M. Regarding current trading prices, MITI is priced at $0.12, while EMOR trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas EMOR's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to EMOR's ROE of +0.02%. Regarding short-term risk, MITI is less volatile compared to EMOR. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check EMOR's competition here
MITI vs VASO Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, VASO has a market cap of 29M. Regarding current trading prices, MITI is priced at $0.12, while VASO trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas VASO's P/E ratio is 8.25. In terms of profitability, MITI's ROE is +0.17%, compared to VASO's ROE of +0.09%. Regarding short-term risk, MITI is more volatile compared to VASO. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check VASO's competition here
MITI vs RTNXF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, MITI is priced at $0.12, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, MITI's ROE is +0.17%, compared to RTNXF's ROE of -6.31%. Regarding short-term risk, MITI is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check RTNXF's competition here
MITI vs DGNOF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, DGNOF has a market cap of 21.8M. Regarding current trading prices, MITI is priced at $0.12, while DGNOF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas DGNOF's P/E ratio is -5.35. In terms of profitability, MITI's ROE is +0.17%, compared to DGNOF's ROE of +30.80%. Regarding short-term risk, MITI is more volatile compared to DGNOF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check DGNOF's competition here
MITI vs HDSLF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, MITI is priced at $0.12, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, MITI's ROE is +0.17%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, MITI is more volatile compared to HDSLF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check HDSLF's competition here
MITI vs THKKF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, MITI is priced at $0.12, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas THKKF's P/E ratio is -1.51. In terms of profitability, MITI's ROE is +0.17%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, MITI is more volatile compared to THKKF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check THKKF's competition here
MITI vs CRVW Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CRVW has a market cap of 17M. Regarding current trading prices, MITI is priced at $0.12, while CRVW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CRVW's P/E ratio is -2.91. In terms of profitability, MITI's ROE is +0.17%, compared to CRVW's ROE of +0.12%. Regarding short-term risk, MITI is more volatile compared to CRVW. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check CRVW's competition here
MITI vs MNNDF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, MITI is priced at $0.12, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, MITI's ROE is +0.17%, compared to MNNDF's ROE of N/A. Regarding short-term risk, MITI is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check MNNDF's competition here
MITI vs WLSS Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, WLSS has a market cap of 12.7M. Regarding current trading prices, MITI is priced at $0.12, while WLSS trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas WLSS's P/E ratio is -460.00. In terms of profitability, MITI's ROE is +0.17%, compared to WLSS's ROE of +0.33%. Regarding short-term risk, MITI is less volatile compared to WLSS. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check WLSS's competition here
MITI vs BRGX Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, BRGX has a market cap of 12.3M. Regarding current trading prices, MITI is priced at $0.12, while BRGX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas BRGX's P/E ratio is -1.27. In terms of profitability, MITI's ROE is +0.17%, compared to BRGX's ROE of +5.32%. Regarding short-term risk, MITI is more volatile compared to BRGX. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check BRGX's competition here
MITI vs PBSV Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, PBSV has a market cap of 11M. Regarding current trading prices, MITI is priced at $0.12, while PBSV trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas PBSV's P/E ratio is -48.00. In terms of profitability, MITI's ROE is +0.17%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, MITI is more volatile compared to PBSV. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check PBSV's competition here
MITI vs CMHSF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CMHSF has a market cap of 9.8M. Regarding current trading prices, MITI is priced at $0.12, while CMHSF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CMHSF's P/E ratio is -3.63. In terms of profitability, MITI's ROE is +0.17%, compared to CMHSF's ROE of +0.28%. Regarding short-term risk, MITI is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check CMHSF's competition here
MITI vs CDXFF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, MITI is priced at $0.12, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, MITI's ROE is +0.17%, compared to CDXFF's ROE of +0.70%. Regarding short-term risk, MITI is more volatile compared to CDXFF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check CDXFF's competition here
MITI vs UDOCF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, UDOCF has a market cap of 8.7M. Regarding current trading prices, MITI is priced at $0.12, while UDOCF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas UDOCF's P/E ratio is -2.51. In terms of profitability, MITI's ROE is +0.17%, compared to UDOCF's ROE of +62.04%. Regarding short-term risk, MITI is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check UDOCF's competition here
MITI vs HBCNF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, MITI is priced at $0.12, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, MITI's ROE is +0.17%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, MITI is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check HBCNF's competition here
MITI vs SPLTF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, MITI is priced at $0.12, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, MITI's ROE is +0.17%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, MITI is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check SPLTF's competition here
MITI vs CMPD Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CMPD has a market cap of 7.9M. Regarding current trading prices, MITI is priced at $0.12, while CMPD trades at $6.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CMPD's P/E ratio is -14.93. In terms of profitability, MITI's ROE is +0.17%, compared to CMPD's ROE of -0.04%. Regarding short-term risk, MITI is more volatile compared to CMPD. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check CMPD's competition here
MITI vs VYND Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, VYND has a market cap of 7.9M. Regarding current trading prices, MITI is priced at $0.12, while VYND trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas VYND's P/E ratio is -43.00. In terms of profitability, MITI's ROE is +0.17%, compared to VYND's ROE of +0.92%. Regarding short-term risk, MITI is more volatile compared to VYND. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check VYND's competition here
MITI vs CRBKF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, MITI is priced at $0.12, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, MITI's ROE is +0.17%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, MITI is more volatile compared to CRBKF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check CRBKF's competition here
MITI vs DOCRF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, MITI is priced at $0.12, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, MITI's ROE is +0.17%, compared to DOCRF's ROE of -1.12%. Regarding short-term risk, MITI is more volatile compared to DOCRF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check DOCRF's competition here
MITI vs IQAIF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, MITI is priced at $0.12, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas IQAIF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to IQAIF's ROE of -0.17%. Regarding short-term risk, MITI is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check IQAIF's competition here
MITI vs AIMLF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, AIMLF has a market cap of 4.4M. Regarding current trading prices, MITI is priced at $0.12, while AIMLF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas AIMLF's P/E ratio is -1.29. In terms of profitability, MITI's ROE is +0.17%, compared to AIMLF's ROE of -3.31%. Regarding short-term risk, MITI is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check AIMLF's competition here
MITI vs CBDS Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, MITI is priced at $0.12, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CBDS's P/E ratio is -1.49. In terms of profitability, MITI's ROE is +0.17%, compared to CBDS's ROE of +1.18%. Regarding short-term risk, MITI is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check CBDS's competition here
MITI vs RQHTF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, RQHTF has a market cap of 2.6M. Regarding current trading prices, MITI is priced at $0.12, while RQHTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, MITI's ROE is +0.17%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, MITI is more volatile compared to RQHTF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check RQHTF's competition here
MITI vs CSOC Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CSOC has a market cap of 2.5M. Regarding current trading prices, MITI is priced at $0.12, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CSOC's P/E ratio is 0.30. In terms of profitability, MITI's ROE is +0.17%, compared to CSOC's ROE of -0.99%. Regarding short-term risk, MITI is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check CSOC's competition here
MITI vs RYAHF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, RYAHF has a market cap of 2.2M. Regarding current trading prices, MITI is priced at $0.12, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, MITI's ROE is +0.17%, compared to RYAHF's ROE of +14.95%. Regarding short-term risk, MITI is more volatile compared to RYAHF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check RYAHF's competition here
MITI vs RSLT Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, RSLT has a market cap of 2.2M. Regarding current trading prices, MITI is priced at $0.12, while RSLT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas RSLT's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to RSLT's ROE of N/A. Regarding short-term risk, MITI is less volatile compared to RSLT. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check RSLT's competition here
MITI vs EBYH Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, EBYH has a market cap of 2M. Regarding current trading prices, MITI is priced at $0.12, while EBYH trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas EBYH's P/E ratio is -5.68. In terms of profitability, MITI's ROE is +0.17%, compared to EBYH's ROE of +0.14%. Regarding short-term risk, MITI is less volatile compared to EBYH. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check EBYH's competition here
MITI vs MDBIF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MDBIF has a market cap of 1.6M. Regarding current trading prices, MITI is priced at $0.12, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MDBIF's P/E ratio is -0.25. In terms of profitability, MITI's ROE is +0.17%, compared to MDBIF's ROE of -0.12%. Regarding short-term risk, MITI is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check MDBIF's competition here
MITI vs EKGGF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, EKGGF has a market cap of 908.9K. Regarding current trading prices, MITI is priced at $0.12, while EKGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas EKGGF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to EKGGF's ROE of +1.04%. Regarding short-term risk, MITI is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check EKGGF's competition here
MITI vs PPJE Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, PPJE has a market cap of 890.5K. Regarding current trading prices, MITI is priced at $0.12, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas PPJE's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to PPJE's ROE of -0.00%. Regarding short-term risk, MITI is more volatile compared to PPJE. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check PPJE's competition here
MITI vs NDATF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, NDATF has a market cap of 826.5K. Regarding current trading prices, MITI is priced at $0.12, while NDATF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas NDATF's P/E ratio is -2.00. In terms of profitability, MITI's ROE is +0.17%, compared to NDATF's ROE of -0.64%. Regarding short-term risk, MITI is less volatile compared to NDATF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check NDATF's competition here
MITI vs EVAHF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, EVAHF has a market cap of 662.2K. Regarding current trading prices, MITI is priced at $0.12, while EVAHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas EVAHF's P/E ratio is -0.27. In terms of profitability, MITI's ROE is +0.17%, compared to EVAHF's ROE of +0.78%. Regarding short-term risk, MITI is more volatile compared to EVAHF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check EVAHF's competition here
MITI vs DSOL Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, DSOL has a market cap of 622.2K. Regarding current trading prices, MITI is priced at $0.12, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas DSOL's P/E ratio is -0.02. In terms of profitability, MITI's ROE is +0.17%, compared to DSOL's ROE of +0.03%. Regarding short-term risk, MITI is more volatile compared to DSOL. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check DSOL's competition here
MITI vs MDNWF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, MITI is priced at $0.12, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, MITI's ROE is +0.17%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, MITI is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check MDNWF's competition here
MITI vs DTRK Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, DTRK has a market cap of 511.2K. Regarding current trading prices, MITI is priced at $0.12, while DTRK trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas DTRK's P/E ratio is -4.44. In terms of profitability, MITI's ROE is +0.17%, compared to DTRK's ROE of +3.54%. Regarding short-term risk, MITI is less volatile compared to DTRK. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check DTRK's competition here
MITI vs USPS Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, USPS has a market cap of 455.1K. Regarding current trading prices, MITI is priced at $0.12, while USPS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas USPS's P/E ratio is -2.87. In terms of profitability, MITI's ROE is +0.17%, compared to USPS's ROE of +0.62%. Regarding short-term risk, MITI is less volatile compared to USPS. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check USPS's competition here
MITI vs CTVEF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CTVEF has a market cap of 418.1K. Regarding current trading prices, MITI is priced at $0.12, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, MITI's ROE is +0.17%, compared to CTVEF's ROE of +0.17%. Regarding short-term risk, MITI is less volatile compared to CTVEF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check CTVEF's competition here
MITI vs MDRM Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MDRM has a market cap of 382.6K. Regarding current trading prices, MITI is priced at $0.12, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MDRM's P/E ratio is -0.30. In terms of profitability, MITI's ROE is +0.17%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, MITI is more volatile compared to MDRM. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check MDRM's competition here
MITI vs LVCE Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, LVCE has a market cap of 381.9K. Regarding current trading prices, MITI is priced at $0.12, while LVCE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas LVCE's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to LVCE's ROE of N/A. Regarding short-term risk, MITI is less volatile compared to LVCE. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check LVCE's competition here
MITI vs ACHKF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, MITI is priced at $0.12, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, MITI's ROE is +0.17%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, MITI is more volatile compared to ACHKF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check ACHKF's competition here
MITI vs NHIQ Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, MITI is priced at $0.12, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas NHIQ's P/E ratio is -0.00. In terms of profitability, MITI's ROE is +0.17%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, MITI is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check NHIQ's competition here
MITI vs EWLL Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, EWLL has a market cap of 185.1K. Regarding current trading prices, MITI is priced at $0.12, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas EWLL's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to EWLL's ROE of +0.13%. Regarding short-term risk, MITI is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check EWLL's competition here
MITI vs ALDNF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, MITI is priced at $0.12, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas ALDNF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to ALDNF's ROE of +0.55%. Regarding short-term risk, MITI is more volatile compared to ALDNF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check ALDNF's competition here
MITI vs TSTTF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, TSTTF has a market cap of 145.8K. Regarding current trading prices, MITI is priced at $0.12, while TSTTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas TSTTF's P/E ratio is -0.73. In terms of profitability, MITI's ROE is +0.17%, compared to TSTTF's ROE of -0.02%. Regarding short-term risk, MITI is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check TSTTF's competition here
MITI vs EMYSF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, EMYSF has a market cap of 142.2K. Regarding current trading prices, MITI is priced at $0.12, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas EMYSF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to EMYSF's ROE of +2.20%. Regarding short-term risk, MITI is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check EMYSF's competition here
MITI vs RVRC Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, RVRC has a market cap of 117.5K. Regarding current trading prices, MITI is priced at $0.12, while RVRC trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas RVRC's P/E ratio is -0.32. In terms of profitability, MITI's ROE is +0.17%, compared to RVRC's ROE of +0.02%. Regarding short-term risk, MITI is less volatile compared to RVRC. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check RVRC's competition here
MITI vs NEWUF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, NEWUF has a market cap of 86.6K. Regarding current trading prices, MITI is priced at $0.12, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas NEWUF's P/E ratio is -0.02. In terms of profitability, MITI's ROE is +0.17%, compared to NEWUF's ROE of +0.88%. Regarding short-term risk, MITI is more volatile compared to NEWUF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check NEWUF's competition here
MITI vs PASO Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, MITI is priced at $0.12, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas PASO's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to PASO's ROE of +6.20%. Regarding short-term risk, MITI is more volatile compared to PASO. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check PASO's competition here
MITI vs LFCOF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, LFCOF has a market cap of 71.6K. Regarding current trading prices, MITI is priced at $0.12, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, MITI's ROE is +0.17%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, MITI is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check LFCOF's competition here
MITI vs REFG Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, MITI is priced at $0.12, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas REFG's P/E ratio is -0.01. In terms of profitability, MITI's ROE is +0.17%, compared to REFG's ROE of +0.01%. Regarding short-term risk, MITI is more volatile compared to REFG. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check REFG's competition here
MITI vs SOFE Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, MITI is priced at $0.12, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas SOFE's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, MITI is less volatile compared to SOFE. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check SOFE's competition here
MITI vs HDVY Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, MITI is priced at $0.12, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas HDVY's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to HDVY's ROE of +15.89%. Regarding short-term risk, MITI is less volatile compared to HDVY. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check HDVY's competition here
MITI vs MDXL Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MDXL has a market cap of 41.1K. Regarding current trading prices, MITI is priced at $0.12, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MDXL's P/E ratio is -0.01. In terms of profitability, MITI's ROE is +0.17%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, MITI is less volatile compared to MDXL. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check MDXL's competition here
MITI vs IGRW Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, MITI is priced at $0.12, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas IGRW's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to IGRW's ROE of -2.28%. Regarding short-term risk, MITI is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check IGRW's competition here
MITI vs WMGR Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, MITI is priced at $0.12, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas WMGR's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to WMGR's ROE of +0.53%. Regarding short-term risk, MITI is more volatile compared to WMGR. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check WMGR's competition here
MITI vs SSYNF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, MITI is priced at $0.12, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, MITI's ROE is +0.17%, compared to SSYNF's ROE of N/A. Regarding short-term risk, MITI is more volatile compared to SSYNF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check SSYNF's competition here
MITI vs TTBLF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, MITI is priced at $0.12, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, MITI's ROE is +0.17%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, MITI is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check TTBLF's competition here
MITI vs NMXS Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, NMXS has a market cap of 18.8K. Regarding current trading prices, MITI is priced at $0.12, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas NMXS's P/E ratio is -0.05. In terms of profitability, MITI's ROE is +0.17%, compared to NMXS's ROE of -2.50%. Regarding short-term risk, MITI is less volatile compared to NMXS. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check NMXS's competition here
MITI vs NHEL Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, MITI is priced at $0.12, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas NHEL's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to NHEL's ROE of +7.36%. Regarding short-term risk, MITI is more volatile compared to NHEL. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check NHEL's competition here
MITI vs FDBH Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, FDBH has a market cap of 15K. Regarding current trading prices, MITI is priced at $0.12, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas FDBH's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, MITI is more volatile compared to FDBH. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check FDBH's competition here
MITI vs ORHB Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, ORHB has a market cap of 13.8K. Regarding current trading prices, MITI is priced at $0.12, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas ORHB's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to ORHB's ROE of +1.70%. Regarding short-term risk, MITI is more volatile compared to ORHB. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check ORHB's competition here
MITI vs BNVIF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, BNVIF has a market cap of 13.3K. Regarding current trading prices, MITI is priced at $0.12, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas BNVIF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, MITI is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check BNVIF's competition here
MITI vs HLTT Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, MITI is priced at $0.12, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas HLTT's P/E ratio is -0.00. In terms of profitability, MITI's ROE is +0.17%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, MITI is more volatile compared to HLTT. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check HLTT's competition here
MITI vs CGNSF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, MITI is priced at $0.12, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CGNSF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, MITI is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check CGNSF's competition here
MITI vs MOSTQ Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, MITI is priced at $0.12, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, MITI's ROE is +0.17%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, MITI is more volatile compared to MOSTQ. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check MOSTQ's competition here
MITI vs ACNV Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, MITI is priced at $0.12, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas ACNV's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to ACNV's ROE of +0.85%. Regarding short-term risk, MITI is more volatile compared to ACNV. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check ACNV's competition here
MITI vs AHGIF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, MITI is priced at $0.12, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas AHGIF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, MITI is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check AHGIF's competition here
MITI vs BBLNF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, MITI is priced at $0.12, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas BBLNF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, MITI is more volatile compared to BBLNF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check BBLNF's competition here
MITI vs ETAOF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, ETAOF has a market cap of 2K. Regarding current trading prices, MITI is priced at $0.12, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas ETAOF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, MITI is more volatile compared to ETAOF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check ETAOF's competition here
MITI vs ICCO Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, ICCO has a market cap of 2K. Regarding current trading prices, MITI is priced at $0.12, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas ICCO's P/E ratio is -0.01. In terms of profitability, MITI's ROE is +0.17%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, MITI is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check ICCO's competition here
MITI vs HSCHF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, HSCHF has a market cap of 1.3K. Regarding current trading prices, MITI is priced at $0.12, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas HSCHF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to HSCHF's ROE of +1.98%. Regarding short-term risk, MITI is more volatile compared to HSCHF. This indicates potentially higher risk in terms of short-term price fluctuations for MITI.Check HSCHF's competition here
MITI vs PCYS Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, MITI is priced at $0.12, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas PCYS's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, MITI is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check PCYS's competition here
MITI vs CNONF Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, CNONF has a market cap of 1.1K. Regarding current trading prices, MITI is priced at $0.12, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas CNONF's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, MITI is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check CNONF's competition here
MITI vs OLMM Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, MITI is priced at $0.12, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas OLMM's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to OLMM's ROE of +4.54%. Regarding short-term risk, MITI is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check OLMM's competition here
MITI vs LGBI Comparison March 2026
MITI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MITI stands at 1.2M. In comparison, LGBI has a market cap of 50. Regarding current trading prices, MITI is priced at $0.12, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MITI currently has a P/E ratio of -0.16, whereas LGBI's P/E ratio is N/A. In terms of profitability, MITI's ROE is +0.17%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, MITI is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for MITI.Check LGBI's competition here